Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Emcure PharmaceuticalsNSE:EMCURE +0.69%41 Days Inventory is 218.13 as of Mar. 2026, which is 1% above its 10-year median of 215.37. GuruFocus rates NSE:EMCURE with a GF Score™ of 41/100. The stock has 5 warning signs investors should review. Among 923 Drug Manufacturers companies, Emcure Pharmaceuticals ranks worse than 69.12% on this metric.
The historical rank and industry rank for Emcure Pharmaceuticals's Days Inventory or its related term are showing as below:
NSE:EMCURE'
s Days Inventory Range Over the Past 10 Years
Min: 200.5 Med: 215.37 Max: 276.91
Current: 220.72
During the past 6 years, Emcure Pharmaceuticals's highest Days Inventory was 276.91. The lowest was 200.50. And the median was 215.37.
NSE:EMCURE's Days Inventory is ranked worse than 69.12% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.38
vs NSE:EMCURE: 220.72
Inventory Turnover measures how fast the company turns over its inventory within a year.
Emcure Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.42.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Emcure Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.97.
Emcure Pharmaceuticals (NSE:EMCURE) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Emcure Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Emcure Pharmaceuticals's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Emcure Pharmaceuticals Days Inventory Related Terms
Emcure Pharmaceuticals Days Inventory Historical Data
* Premium members only.
The historical data trend for Emcure Pharmaceuticals's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:EMCURE vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Emcure Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Emcure Pharmaceuticals Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Emcure Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Emcure Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Emcure Pharmaceuticals (NSE:EMCURE) has a Days Inventory of 218.13 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Emcure Pharmaceuticals and its competitors. This is near median its historical median of 215.37. Over the past decade, Emcure Pharmaceuticals' Days Inventory has ranged from 200.50 to 276.91. According to the industry distribution chart, Emcure Pharmaceuticals ranks #638 out of 923 companies in the Drug Manufacturers industry, placing it in the top 69.1%.
Is Emcure Pharmaceuticals' Days Inventory too high?
Emcure Pharmaceuticals' current Days Inventory of 218.13 is near median its 10-year median of 215.37. Over the past 10 years, this metric has ranged from a low of 200.50 to a high of 276.91. The Drug Manufacturers industry median Days Inventory is 164.38. Emcure Pharmaceuticals' value of 218.13 is 32.7% above this industry median. Based on the distribution chart, Emcure Pharmaceuticals ranks #638 out of 923 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Emcure Pharmaceuticals has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Emcure Pharmaceuticals' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Emcure Pharmaceuticals ranks #638 out of 923 companies for Days Inventory. This places Emcure Pharmaceuticals in the lower half of its industry. The industry median Days Inventory is 164.38. Emcure Pharmaceuticals' value of 218.13 is 32.7% above this benchmark. Historically, Emcure Pharmaceuticals' own Days Inventory has ranged from 200.50 to 276.91 over the past decade. While the company's 10-year median is 215.37 vs. the industry median of 164.38, Emcure Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.38, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Emcure Pharmaceuticals's current Days Inventory of 218.13 is 32.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Emcure Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Emcure Pharmaceuticals's current Days Inventory is 218.13, which is near median its own 10-year median of 215.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Emcure Pharmaceuticals stock overvalued right now?
Emcure Pharmaceuticals (NSE:EMCURE) has a current Days Inventory of 218.13. The current Days Inventory is 218.13, which is near median its 10-year median of 215.37 and 32.7% above the Drug Manufacturers industry median of 164.38. Emcure Pharmaceuticals' overall GF Score™ is 41/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Emcure Pharmaceuticals (NSE:EMCURE), the current Days Inventory is 218.13 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Emcure Pharmaceuticals Ltd an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several therapeutic areas. Its portfolio includes orals including solids, liquid orals and dry syrup/suspensions., injectables such as vials and pre-filled syringes, and forms such as lyophilized & liquid and biotherapeutics. The company operates in Derma, Women's Health, Cardiovascular, Neurology, Oncology, Vaccines, and Anti-infectives. Geographically, it operates in India, Europe, Canada, Vietnam, Dubai, and Other Countries.
41GF Score
Get the complete analysis for NSE:EMCURE
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:EMCURE has been successfully added to your 
